Status:
TERMINATED
Quantitative Imaging and Proton Spectroscopy in Multiple Sclerosis
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
7-110 years
Phase:
NA
Brief Summary
The primary purpose of this study is to detect changes in the brain that may be associated with multiple sclerosis. Results will be compared to age matched controls. Investigators will assess lesions ...
Eligibility Criteria
Inclusion
- Patients with known MS diagnosis
- Age 7-110 years
- Males or females
Exclusion
- Medically unstable
- Artificial implants in the body
- Pregnant
- Normal Controls
Key Trial Info
Start Date :
August 1 1991
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
69 Patients enrolled
Trial Details
Trial ID
NCT01226654
Start Date
August 1 1991
End Date
April 1 2016
Last Update
August 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Medical Center
New York, New York, United States, 10016